Go to the list of all blogs
published in Blogs
Apr 21, 2026

RTX (RTX): +7% YTD Gains on Q1 Earnings Beat and $11.9 Billion Defense Deal

Key Takeaways

  • RTX reported Q1 2026 earnings that significantly exceeded expectations, with adjusted EPS of $1.78 and revenue of $22.1 billion, leading to raised full-year guidance.
  • A major U.S. approval for a potential $11.9 billion combat systems deal with Germany underscores RTX's role in international defense.
  • Analyst consensus rates the stock as Overweight, with an average price target around $219.
  • Strong demand in munitions and commercial aviation supports ongoing backlog growth and cash flow generation.
  • RTX's $251 billion backlog positions it well amid geopolitical tensions and air travel recovery.

A Snapshot of RTX's Current Market Position

In recent weeks, RTX stock has shown resilience amid broader market fluctuations, supported by strong tailwinds in the aerospace and defense sectors. Trading near the upper end of its 52-week range—with a high of $214.50 and a low of $112.63—the shares reflect growing investor confidence in the company's execution. Year-to-date gains exceed 7%, fueled by steady demand for military hardware and commercial aftermarket services. With a market capitalization over $263 billion, RTX maintains its position as a leader in high-tech systems. Recent sessions have highlighted positive momentum from operational performance and contract wins, setting the stage for continued interest. I also checked this using Tickeron’s AI Screener to compare how RTX stacks up against peers in the industry.

Recent Developments Driving RTX's Momentum

RTX Corporation has drawn significant investor focus lately, thanks to key operational updates and geopolitical developments. On April 21, 2026, the company posted Q1 results that beat Wall Street estimates, with adjusted EPS of $1.78—surpassing the $1.52 forecast—and revenue of $22.1 billion against expectations of about $21.4 billion. This led RTX to raise its full-year 2026 profit and revenue guidance, pointing to sustained aftermarket sales, strong weapons demand, and commercial aviation growth. Shares climbed over 3% following the news, signaling optimism around execution and supply chain progress.

Adding to the earnings tailwinds, the U.S. State Department approved a potential $11.9 billion sale of combat systems to Germany, involving RTX and Lockheed Martin, announced about 18 hours earlier. This strengthens RTX's international defense presence and highlights rising European security demands. RTX also won a contract for advanced jammers from the Australian government, showcasing its electronic warfare capabilities and expanding footprint in the Asia-Pacific. These wins have helped counter near-term macroeconomic pressures, such as interest rate outlooks. From what I see, patterns like these align with what Tickeron’s AI Trend Prediction Engine has flagged for defense names.

Analyst reactions have been mixed yet generally positive. Jefferies kept a Hold rating on April 13, trimming its target to $210, while the consensus from 26 firms holds at Overweight with an average target of $219.36. Earlier in the quarter, the stock weathered industrial sector volatility but recovered on defense spending strength. No significant guidance changes or SEC filings have hurt the fundamentals. Overall, these factors—solid quarterly results, new contracts, and an upgraded outlook—have driven price gains, supporting RTX's premium valuation in a sector lifted by global tensions and aviation recovery.

Tickeron's Trending AI Robots

In my analysis workflow, I often reference Tickeron’s Trending AI Robots page, which features the top 25 AI-powered trading bots from over 350 on the platform. These bots trade thousands of tickers across stocks, ETFs, and crypto, selected for their strong performance in today's markets with strategies like swing trading, trend following, and volatility plays—spanning timeframes from 5 minutes to 55 days. Key metrics include annualized returns of 15% to 168%, win rates from 54% to 88%, and profit factors up to 11.7. For example, bots focused on Aerospace & Defense tickers such as KTOS and RKLB, plus ETFs like ITA, offer targeted opportunities. This resource helps me review backtests and live results to refine my approach.

RTX's 2026 Outlook and Key Factors to Watch

Looking ahead to 2026, several themes from RTX's January guidance and recent updates warrant close attention. Full-year sales are expected at $92-93 billion, with adjusted EPS of $6.60-$6.80 and free cash flow of $8.25-$8.75 billion, powered by commercial engine aftermarket expansion and defense awards. The record $251 billion backlog offers strong visibility, though progress on Pratt & Whitney's geared turbofan engines remains key after prior supply hurdles.

Upside potential comes from rising defense budgets—especially U.S. and allies' focus on munitions and hypersonics—plus commercial aviation recovery. Risks involve geopolitical changes impacting contracts, raw material inflation, and M&A regulatory hurdles. Success in electronic warfare, next-gen systems, and cost controls will matter. Industry shifts toward sustainable aviation fuels and defense digitalization may provide further support. I'll be tracking quarterly backlog conversion, segment margins, and macro indicators for signs of ongoing strength. One thing that stands out is how this backlog insulates RTX amid uncertainty.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: RTX

RTX sees MACD Histogram crosses below signal line

RTX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RTX moved out of overbought territory on August 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 57 similar instances where the indicator moved out of overbought territory. In of the 57 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RTX as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for RTX moved above the 200-day moving average on July 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RTX advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

RTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 332 cases where RTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. RTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.263) is normal, around the industry mean (7.037). P/E Ratio (36.956) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (2.608) is also within normal values, averaging (8.077). Dividend Yield (0.013) settles around the average of (0.017) among similar stocks. P/S Ratio (3.058) is also within normal values, averaging (20.174).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
1000 Wilson Boulevard
Phone
+1 781 522-3000
Employees
185000
Web
https://www.rtx.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.